Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Becker-Merok

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lupus|April 28, 2009
Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosusA Becker-Merok, Jc Nossent
Lupus|November 4, 2006
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and timeA Becker-Merok, C Nikolaisen, H C Nossent
Scandinavian Journal of Rheumatology|September 30, 1999
Fibrosing alveolitis predating microscopic polyangiitisA Becker-Merok, J C Nossent, N Ritland
Lupus|December 6, 2012
Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activationA Becker-Merok, G Østli-Eilersten, S Lester, et al.
Lupus|March 23, 2011
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosusG Ø Eilertsen, C Nikolaisen, A Becker-Merok, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lupus|April 28, 2009
Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosusA Becker-Merok, Jc Nossent
Lupus|November 4, 2006
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and timeA Becker-Merok, C Nikolaisen, H C Nossent
Scandinavian Journal of Rheumatology|September 30, 1999
Fibrosing alveolitis predating microscopic polyangiitisA Becker-Merok, J C Nossent, N Ritland
Lupus|December 6, 2012
Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activationA Becker-Merok, G Østli-Eilersten, S Lester, et al.
Lupus|March 23, 2011
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosusG Ø Eilertsen, C Nikolaisen, A Becker-Merok, et al.
Pageof 1